Benjamin Brod

Benjamin Brod has extensive experience in the legal and transactions field. Benjamin currently holds the position of Chief Commercial Transactions Officer at Agenus since March 2023. Prior to joining Agenus, they worked at Novartis from 2014 to 2023, holding roles such as Global Head Legal for Oncology BD&L and Portfolio Management, Executive Director - Senior Counsel, and Senior Legal Counsel for M&A. Before Novartis, Benjamin worked at Shearman & Sterling LLP as an M&A Associate from 2010 to 2014, where they gained experience in mergers and acquisitions, transaction structuring, corporate organization, corporate governance, and securities laws.

Benjamin Brod pursued their education at the New York University School of Law from 2006 to 2009, where they completed a Doctor of Law (JD) degree. There is no specific field of study mentioned. Prior to that, from 2000 to 2004, Benjamin attended Duke University, where they obtained an AB degree in Political Science.